Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.07. | Bactiguard Q2 Loss Narrows | - | RTTNews | ||
15.07. | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2025 | 72 | GlobeNewswire (Europe) | Positive EBITDA momentum carried forward in Q2
Second quarter 2025 (April - June)
Total revenue amounted to SEK 52.1 (60.9) million, a decrease of SEK 8.8 million corresponding to 14.4%.
Net sales... ► Artikel lesen | |
08.07. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's interim report for the second quarter 2025 | 1 | Cision News | ||
15.05. | Bactiguard Holding AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | 180 | GlobeNewswire (Europe) | At Bactiguard Holding AB's (publ) Annual General Meeting (AGM) on 15 May 2025, the following resolutions were made:
The AGM adopted the income statements and balance sheets for 2024 and decided that... ► Artikel lesen | |
24.04. | Bactiguard Holding AB: Bactiguard Holding AB's interim report first quarter 2025 | 107 | GlobeNewswire (Europe) | Continued profitability and revenue growth for Bactiguard
First quarter 2025 (January - March)
Total revenue amounted to SEK 62.7 (58.8) million, an increase of SEK 3.9 million corresponding to 6.7%.
Net... ► Artikel lesen | |
17.04. | BACTIGUARD HOLDING AB: Bactiguard Holding AB's Annual and Sustainability Report 2024 | 1 | Cision News | ||
16.04. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's interim report for the first quarter 2025 | 1 | Cision News | ||
10.04. | BACTIGUARD HOLDING AB: Notice to attend the Annual General Meeting of Bactiguard Holding AB | 1 | Cision News | ||
BACTIGUARD Aktie jetzt für 0€ handeln | |||||
03.04. | BACTIGUARD HOLDING AB: The Nomination Committee's proposal for Board of Directors to the 2025 Annual General Meeting | 2 | Cision News | ||
05.03. | BACTIGUARD HOLDING AB: Bactiguard announces updated strategic and financial targets | 3 | Cision News | ||
06.02. | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2024 | 131 | GlobeNewswire (Europe) | License focused strategy delivered increased revenues and profitability
Fourth quarter 2024 (October - December)
Total revenue amounted to SEK ?68.3? (?61.3?) million, an increase of SEK ?6.9?... ► Artikel lesen | |
30.01. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's year-end report for 2024 | 3 | Cision News | ||
24.10.24 | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2024 | 223 | GlobeNewswire (Europe) | Bactiguard delivers positive EBITDA and initiates review of 2028 financial targets due to previously announced agreement termination
Third quarter 2024 (July - September)
Total revenue amounted to... ► Artikel lesen | |
02.10.24 | Bactiguard Holding AB: Zimmer Biomet terminates agreement for multiple orthopedic product segments - trauma agreement remains in effect | 410 | GlobeNewswire (Europe) | Zimmer Biomet has informed Bactiguard that they terminate the license agreement signed in 2022 covering multiple orthopedic product segments. The reason stated is the more complex and lengthier path... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TELADOC HEALTH | 7,021 | +0,62 % | Teladoc Health, Inc. - 8-K, Current Report | ||
ROKU | 77,18 | +0,80 % | Could Roku Stock 10x by 2030? | ||
SERNOVA BIOTHERAPEUTICS | 0,112 | -4,27 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung geben | EQS-News: SYNLAB AG
/ Schlagwort(e): Kooperation/Studienergebnisse
Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung... ► Artikel lesen | |
BOSTON SCIENTIFIC | 90,20 | -0,22 % | Boston Scientific-Aktie gewinnt 4,55 Prozent (92,00 €) | Im Plus liegt gegenwärtig das Wertpapier von Boston Scientific . Die Aktie notiert aktuell bei 92,00 Euro. Am Aktienmarkt liegt der Anteilsschein von Boston Scientific derzeit im Plus. Das Wertpapier... ► Artikel lesen | |
PAUL HARTMANN | 241,00 | -1,23 % | Dividendenbekanntmachungen (02.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,175 USD 0,155 EUR AKER ASA NO0010234552 26,5 NOK 2,2495 EUR ALIMAK GROUP AB SE0007158910 3 SEK 0... ► Artikel lesen | |
SYSMEX | 15,000 | +2,04 % | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
ADDLIFE | 15,410 | +0,85 % | AddLife AB: Interim Report January 1 - June 30, 2025 | Continued improvement in margins and profit"The companies within AddLife continue to develop in line with our priorities. Margins are strengthening in both business areas thanks to continuous development... ► Artikel lesen | |
EMBECTA | 9,700 | 0,00 % | Embecta Corp.: embecta to Report Fiscal Third Quarter 2025 Financial Results | ||
ENOVIS | 23,600 | +1,72 % | Enovis Corporation: Enovis Announces First Quarter 2025 Results | Continued commercial momentum with first-quarter sales growth of 8% on a reported basis and strong adjusted EBITDA margin expansion First-quarter Reconstructive sales grew 11% year-over-year on a reported... ► Artikel lesen | |
COVETRUS | - | - | INSPIRE VETERINARY PARTNERS, INC.: Inspire Veterinary Partners Announces AI Integration into Practice Management Software in Partnership with Leading Software Provider Covetrus | New software integration is among the first multi-unit operators to roll out AI note integration directly into the Company's medical software VIRGINIA BEACH, VA / ACCESS Newswire / June 10, 2025 / Inspire... ► Artikel lesen | |
KANGJI MEDICAL | 0,928 | -100,00 % | XFRA 50J: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILKANGJI MED.HLDS... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,900 | +2,97 % | Ohne Wolfram kein Hightech - dieser Flaschenhals bringt Rendite: Almonty, Siemens Healthineers, Intel | Wolfram gilt aufgrund seiner Härte und Hitzebeständigkeit als Rüstungsmetall. Doch es ist auch einer der unsichtbaren Motoren der Hightech-Industrie. Wir erklären anhand von Beispielen aus der Medizintechnik... ► Artikel lesen | |
FRESENIUS | 42,200 | +0,74 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,790 | -0,35 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 41,50 Euro auf "Underweight" belassen. Analyst David Adlington passte seinen am Montag vorliegenden... ► Artikel lesen |